DrugPatentWatch Database Preview

DrugPatentWatch Database Updates: New Patent Additions

« Back to Dashboard

DrugPatentWatch Database Updates: New Patent Additions

These are patents which have been reported by the FDA since the last major update; they are not yet in the main database.

Applicant	Tradename	Generic Name	Dosage	NDA	Number	Approval Date	Type	RLD	Patent No.	Product	Substance	Delist_Flag	Patent Expiration	Usecode	Patented / Exclusive Use
Avanir Pharms	ONZETRA XSAIL	sumatriptan succinate	POWDER	206099	001	Jan 27, 2016	RX	Yes		Y				U-2011	TREATMENT OF MIGRAINE VIA DELIVERY OF SUMATRIPTAN VIA THE NASAL CAVITY
Paratek Pharms Inc	NUZYRA	omadacycline tosylate	TABLET	209816	001	Oct 2, 2018	RX	Yes						U-2449	TREATMENT OF BACTERIAL SKIN AND SKIN STRUCTURE INFECTION
Astrazeneca Pharms	EPANOVA	omega-3-carboxylic acids	CAPSULE	205060	001	May 5, 2014	DISCN	Yes						U-2447	TREATMENT OF SEVERE HYPERTRIGLYCERIDEMIA (500 MG/DL) IN ADULT PATIENTS AS AN ADJUNCT TO DIET
Optinose Us Inc	XHANCE	fluticasone propionate	SPRAY, METERED	209022	001	Sep 18, 2017	RX	Yes		Y				U-2133	METHOD OF DELIVERING FLUTICASONE PROPIONATE TO A NASAL AIRWAY
Merck Sharp Dohme	NOXAFIL	posaconazole	SOLUTION	205596	001	Mar 13, 2014	RX	Yes		Y
Shire Dev Llc	XIIDRA	lifitegrast	SOLUTION/DROPS	208073	001	Jul 11, 2016	RX	Yes						U-1900	TREATMENT OF THE SIGNS AND SYMPTOMS OF DRY EYE DISEASE (DED)